Most popular

    Health & Science

    Home Health & Science

    Biden Cancer Diagnosis Spurs White House Coverup Accusations

    By
    Madeleine Jackson
    -
    1
    Photo via Gage Skidmore Flickr

    The news of former President Joe Biden’s cancer diagnosis has sent shockwaves across America.

    Biden’s team announced Sunday that he’d been diagnosed with an aggressive form of prostate cancer that had already metastasized to the bone, adding his family would examine suitable treatment for the “management” of the disease.

    The shocking news comes amid heightened scrutiny surrounding the Bidens potential coverup of former President Biden’s mental and physical decline while in office.

    On Monday, Rep. Ronny Jackson (R-TX) accused the Biden White House of a “political cover up” and lashed out at Biden’s then-White House doctor, though not by name, and accused the physician of having failed to deliver “world class care” to Biden and engaging in a “cover up.”

    President Donald Trump posted a message to his Truth Social app on Sunday from himself and First Lady Melania Trump expressing their sympathy and well-wishes for Biden, after it was announced that the former president is battling very serious prostate cancer.

    Trump Jr. likewise initially offered an expression of sympathy, by way of reposting a message on his account at X.

    Sharing a screenshot that included the message “Politics aside, we wish [President Biden] a speedy recover,” Trump Jr. commented “Agreed 100%.”

    In another post three hours later which also included a screenshot, Trump Jr. had a more critical take on the tragic news.

    His screenshot showed a message on the nature of Biden’s particular cancer, and calling into question the timeline of when Democrats, or at least the White House, knew about it.

    “What I want to know is how did Dr. Jill Biden miss stage five metastatic cancer or is this yet another coverup???” he said, with a sarcastic jab at former First Lady Jill Biden.

    The hosts of Fox & Friends were in disbelief Monday morning at Joe Biden’s advanced cancer diagnosis despite the “fantastic medical care” that he receives as a former president.

    “These are the types of things you look for when you get older,” Kilmeade added. “And very curious to see and somewhat discouraging to think someone could have this type of medical attention and have this get to this point.”

    Co-host Charles Hurt added: “Especially because it’s a fairly advanced form so much so that it has metastasized to a bone. And you would think that would give you a lot more time to catch it.”

    Later in the show, the curvy couch welcomed Fox News medical expert Dr. Marc Siegel, who echoed their surprise.

    “Really, really surprising that it’s this advanced at the time of diagnosis,” he said. “Now, you can miss prostate cancer but most of the time regular screening picks it up. A sitting president I would expect to have advanced screening should not be subject to debate what kind of screening.”

    Trump Breaks Silence On Biden’s Cancer Diagnosis

    By
    Patrick Houck
    -
    0
    The White House, Public domain, via Wikimedia Commons

    President Donald Trump expressed sympathy for former President Joe Biden following Sunday’s surprise announcement of Biden’s aggressive prostate cancer diagnosis. In a Truth Social post, Trump stated:

    “Melania and I are saddened to hear about Joe Biden’s recent medical diagnosis. We extend our warmest and best wishes to Jill and the family, and we wish Joe a fast and successful recovery.”

    Biden, 82, was diagnosed with a high-grade, hormone-sensitive prostate cancer that has metastasized to the bone. Biden and his family are currently reviewing treatment plans with his medical team.

    Trump’s message marks a notable moment of bipartisan compassion amid ongoing political tensions.

    In his first public statement following the diagnosis, Biden expressed gratitude for the outpouring of support, saying:

    “Cancer touches us all. Like so many of you, Jill and I have learned that we are the strongest in broken places.”

    The announcement has prompted a wave of bipartisan support, with messages of encouragement from various political figures, including Kamala Harris and Barack Obama.

    However, not all reactions have been as supportive. Donald Trump Jr. initially shared a message wishing President Biden a speedy recovery but later posted a controversial comment questioning how Dr. Jill Biden could have missed signs of advanced cancer, suggesting a possible cover-up. “What I want to know is how did Dr. Jill Biden miss stage five metastatic cancer—or is this yet another cover-up???” Trump Jr. wrote on X (formerly Twitter). His post was widely criticized for its accusatory tone and for failing to note that Jill Biden holds a doctorate in education, not medicine.

    According to Newsweek‘s reporting, the cancer presumably developed rapidly, despite Biden’s routine screenings intended to detect it early:

    A professor of oncology told Newsweek that Joe Biden would have been tested for prostate cancer while in office and it is likely his cancer developed rapidly.

    Gage Skidmore, CC BY-SA 2.0 , via Wikimedia Commons

    Biden’s age and health were dominant concerns among voters during his time as president. The 82-year-old dismissed concerns about his mental acuity, but ultimately dropped his bid for a second term following a disastrous debate performance in June last year. He was replaced as the Democratic nominee by then-Vice President Kamala Harris, who lost to President Donald Trump.

    Questions have been raised about the Biden administration and campaign’s transparency about Biden’s age and cognitive ability. An upcoming book alleges White House aides covered up Biden’s physical and mental decline. However, there is no current indication publicly available that Biden was diagnosed with prostate cancer during his tenure as president.

    …

    Biden’s office said the former president was diagnosed with prostate cancer on Friday, with the cancer cells having spread to the bone.

    Trump Signs Executive Order To Tie US Drug Prices To Global Lows

    By
    Patrick Houck
    -
    0

    On Monday morning, President Donald Trump signed a sweeping executive order aimed at dramatically lowering prescription drug prices in the United States. At the center of the order is a “most favored nation” (MFN) pricing policy, which mandates that the U.S. pay no more for medications than the lowest price paid by any other country. Trump claims the initiative could cut drug prices by 30% to 80%, potentially saving American taxpayers trillions of dollars.

    The MFN policy revives a proposal from Trump’s first term and targets the longstanding disparity in drug costs between the U.S. and other nations. The order also directs the Department of Health and Human Services to begin broad drug price negotiations, while introducing measures to combat anti-competitive practices, expand drug imports, and scrutinize the role of pharmacy benefit managers (PBMs).

    The New York Post reports:

    “What’s been happening is, we’ve been subsidizing other countries throughout the world,” Trump explained at a White House signing ceremony, calling Monday’s action one of his “most important orders.”

    “Some prescription drug and pharmaceutical prices will be reduced almost immediately by 50 to 80 to 90%, he added. “Big Pharma will either abide by this principle voluntarily or we’ll use the power of the federal government to ensure that we are paying the same price.”

    The policy is a revival of Trump’s signature “most favored nation” drive from his first term, with a new push to get foreign countries to take on more of the research and development (R&D) costs that experts say America has disproportionately shouldered.

    “Our Country will finally be treated fairly, and our citizens Healthcare Costs will be reduced by numbers never even thought of before,” the president previously promised on Truth Social Sunday. “The United States will save TRILLIONS OF DOLLARS.”

    The announcement triggered immediate market reaction, with shares of pharmaceutical giants like AstraZeneca and GSK seeing declines. Industry leaders have warned the policy could stifle innovation and competition, arguing it may disincentivize research and development.

    Although the Biden administration previously took steps to lower drug prices through the Inflation Reduction Act, Trump’s executive order takes a more aggressive approach by linking U.S. prices directly to global lows.

    However, the new policy is expected to face significant legal and logistical hurdles, particularly due to the complexity of the U.S. drug pricing system and the opaque nature of international pricing mechanisms.

    © Great America News Desk 2022